Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1238217 | 0.90 | CYP1A2 (0.42) | CYP1A2TP53ALDH1A1CYP3A4CYP2C9 | |
| SCHEMBL4442531 | 0.84 | TP53 (0.55) | CYP1A2TP53ALDH1A1CYP3A4CYP2C9 | |
| SCHEMBL1238019 | 0.79 | TP53 (0.50) | CYP1A2TP53ALDH1A1CYP3A4CYP2C9 | |
| SCHEMBL5179413 | 0.79 | TP53 (0.58) | CYP1A2TP53ALDH1A1GPR84CYP3A4 | |
| SCHEMBL5178494 | 0.77 | TP53 (0.56) | CYP1A2TP53ALDH1A1GPR84CYP3A4 | |
| SCHEMBL21556783 | 0.77 | TP53 (0.56) | CYP1A2TP53ALDH1A1GPR84CYP3A4 | |
| SCHEMBL1044726 | 0.75 | — | — | |
| SCHEMBL2944832 | 0.75 | CYP1A2 (0.33) | CYP1A2TP53ALDH1A1CYP3A4CYP2C9 | |
| SCHEMBL6902175 | 0.74 | GSTP1 (0.31) | — | |
| SCHEMBL4135092 | 0.74 | TP53 (0.69) | CYP1A2TP53ALDH1A1CYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6887499-B2 | Formulation and method for treating skeletal muscle degeneration caused by malnutrition and disease | BABABUNMI ENITAN A (US) | 2005-05-03 | — | — | US | disclosed |
| WO-2004028446-A2 | FORMULATION AND METHOD FOR TREATING SKELETAL MUSCLE DEGENERATION CAUSED BY MALNUTRITION AND DISEASE | BABABUNMI ENITAN A (US) | 2004-04-08 | — | — | WO | disclosed |
| US-20030021858-A1 | Formulation and method for treating skeletal muscle degeneration caused by malnutrition and disease | BABABUNMI ENITAN A (US) | 2003-01-30 | — | — | US | disclosed |
| US-6465021-B2 | Formulation and method for treating skeletal muscle degeneration caused by malnutrition and disease | BABABUNMI ENITAN ABLSOGUN (US) | 2002-10-15 | — | — | US | disclosed |
| US-20020006911-A1 | Formulation and method for treating skeletal muscle degeneration caused by malnutrition and disease | BABABUNMI ENITAN ABLSOGUN (US) | 2002-01-17 | — | — | US | disclosed |